An empty Architecture for compounding.
NanoBase™ Rx.
NanoBase™ Rx is the tri-domain NanoBase™ Architecture offered as an empty excipient for pharmacy compounding and pharmaceutical R&D. It contains no active ingredient. A licensed compounding pharmacist or qualified formulator loads the active, sets the strength and is responsible for the finished preparation. Pensive Beauty® Nanoscience Labs supplies the excipient and its documentation only.
- Category
- Excipient Architecture, supplied empty
- Users
- 503A and 503B compounding pharmacies, pharmaceutical R&D
- Actives
- None. Loaded downstream by a qualified person
- Design logic
- TDA Logic, the tri-domain successor to HLB design
- Size
- ~185 nm design target
- Claims
- None. Excipient only
A modern base for the person who loads the active.
Compounding has long relied on conventional emulsion bases and organogels such as PLO, each a single structure. NanoBase™ Rx offers a tri-domain alternative: nanocolloidal, nanoliposomal and nanomicellar domains in one continuous water phase, supplied empty so the pharmacist or formulator decides what goes into it.
Empty by design
Contains no active. Everything loaded into it is chosen and controlled by the compounding pharmacist or formulator.
Three domains, one base
Designed so ingredients of different chemistry each have a domain that suits them, placed by TDA Logic.
Beyond single-structure bases
Offered for evaluation as an alternative to PLO and other conventional compounding bases.
Yours downstream
The finished preparation, its strength, beyond-use dating and USP 795 and 797 compliance remain with the compounding facility.
NanoBase™ Rx is an excipient. It is not a drug, contains no active ingredient and makes no therapeutic claim. Suitability for any preparation, and all regulatory and clinical responsibility for it, rests with the licensed compounding pharmacist or developing company. Composition, ratios and process are confidential.
Excipient first, then your protocol.
Excipient brief
Request the brief and documents for your facility or R&D programme.
Evaluation quantity
The lab supplies an evaluation quantity of the empty excipient with its documentation.
Your validation
Your team loads, tests and validates under your own protocols and standards.
Ongoing supply
Supply at the volumes your facility needs, quoted per order.
NanoBase™ Rx, answered.
Is NanoBase™ Rx a drug?
No. It is an empty excipient Architecture. It contains no active ingredient and makes no therapeutic claim.
Who loads the active?
A licensed compounding pharmacist or a qualified formulator in a pharmaceutical R&D setting. They choose the active, set the strength and are responsible for the finished preparation.
Is it a cosmetic?
No. NanoBase™ Rx is offered only as an excipient to compounding and pharmaceutical development. The cosmetic NanoBase™ Architectures (Classic, Luxe and Clinical) are separate products.
Who is responsible for beyond-use dating and compliance?
The compounding facility, under USP 795 and 797 where they apply, or the developing company under its own regulatory framework.
Request the NanoBase™ Rx excipient brief.
Tell the lab about your facility or programme and the preparations you are evaluating. The lab replies the same day.
- Empty excipient, no active ingredient
- Documentation for your evaluation
- Your protocols, your validation
team@pensivebeauty.com
508-206-6500
Seffner, Florida
The lab replies the same day, 9 am to 9 pm EST, 7 days a week.